Unplanned pregnancy on a direct oral anticoagulant (Rivaroxaban): A warning
| Autor: | R Neal, M Ruparelia, O Myers, Bethan Myers |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2015 |
| Předmět: |
Rivaroxaban
medicine.medical_specialty Pregnancy business.industry Obstetrics Obstetrics and Gynecology Case Reports 030204 cardiovascular system & hematology Factor ii medicine.disease 03 medical and health sciences 0302 clinical medicine 030220 oncology & carcinogenesis Anesthesia Unplanned pregnancy Childbearing age Oral anticoagulant Medicine Gestation business Breast feeding medicine.drug |
| Popis: | Direct oral anticoagulants (DOACs or NOACs -non-vitamin K oral anticoagulants), as the name suggests, are oral anticoagulants with a direct inhibitory action either against factor X or factor II (thrombin). Pregnant women were excluded from participating in all the large trials of the DOACs and they are considered contra-indicated in pregnancy and breast feeding. We present a case of inadvertent exposure to rivaroxaban in a woman who presented at 25 weeks' gestation. The management of her pregnancy and delivery is described, and the previous published case reports are reviewed with a discussion about the use of DOACs in woman of childbearing age. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|